HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-Term Outcomes After Idiopathic Epiretinal Membrane Surgery.

AbstractPURPOSE:
To report anatomic and logMAR best-corrected visual acuity (BCVA) outcomes with long-term follow-up after pars-plana vitrectomy and epiretinal membrane peeling (PPV-MP).
DESIGN:
A retrospective case-series.
PARTICIPANTS:
Patients with epiretinal membrane (ERM) who underwent PPV-MP performed by one surgeon.
METHODS:
Best-corrected visual acuity (BCVA) was recorded as a logMAR preoperatively and, when available, at 1, 2, 3, 5, 8, 10 years after surgery. The integrity of outer retinal layers was evaluated using spectral domain optical coherence tomography (SD-OCT).
MAIN OUTCOME MEASURES:
Postoperative BCVA at different follow-up visits and its correlation with different OCT parameters.
RESULTS:
Fifty-five eyes of 49 patients were followed postoperatively with a mean of 8.6± 2.6 years (median: 9 years, range 5-16 years). The mean BCVA improved from 0.56±0.29 (20/72) preoperatively to 0.33±0.25 (20/42) at 1 year, 0.29±0.27 (20/38) at 2 years, 0.25±0.28 (20/35) at 3 years, 0.29±0.32 (20/38) at 5 years, 0.28±0.31 (20/38) at 8 years, and 0.28±0.25 (20/38) at 10 years (p<0.001). The BCVA improved at each of the first 3 years postoperatively and remained stable at 5, 8, and 10 years. Postoperative improvement in the integrity of ELM, and EZ, on SD-OCT correlated with improved BCVA.
CONCLUSION:
BCVA continues to improve after PPV-MP during the first 3 years postoperatively and remains stable. Improved anatomic integrity of outer retinal layers correlated with improved BCVA.
AuthorsAbdelrahman M Elhusseiny, Harry W Flynn Jr, William E Smiddy
JournalClinical ophthalmology (Auckland, N.Z.) (Clin Ophthalmol) Vol. 14 Pg. 995-1002 ( 2020) ISSN: 1177-5467 [Print] New Zealand
PMID32280194 (Publication Type: Journal Article)
Copyright© 2020 Elhusseiny et al.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: